Kayexalate® (sodium polystyrene sulfonate) – Safety update
September 6, 2017 – The FDA announced that Kayexalate (sodium polystyrene sulfonate) drug labels will be updated to state that the dose should be separated by at least 3 hours from other orally administered drugs.
Download PDF
